Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GOSS
#3274
Gossamer Bio, Inc. Common Stock
0.4
2
+7.69%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+7.69%
Monthly Change
-84.33%
6 month change
-83.00%
Cambio anual
-63.16%
Cierres anteriores
0.3
9
Open
0.4
2
Bid
Ask
Low
0.4
2
High
0.4
3
Volumen
101
Markets
Acciones
Atención Sanitaria
GOSS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
226.6 M
227.22 M
227.3 M
227.38 M
231.46 M
—
Valuation ratios
Enterprise value
195.06 M
159.47 M
221.01 M
253.37 M
599.8 M
1.23 B
Price to earnings ratio
-8.97
-3.62
-5
-2.02
-3.87
-14.5
Price to sales ratio
2.11
1.78
2
6.93
13.55
24.25
Price to cash flow ratio
-12.73
-59.01
26.69
-1.81
-3.77
-37.89
Price to book ratio
0.87
6.94
1.56
8.84
-5.69
11.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.19
0.1
0.13
0.16
0.23
0.63
Return on equity %
-1.25
1.12
5.86
0.83
0.59
8.4
Return on invested capital %
386.98
—
—
379.01
433.48
—
Gross margin %
100
100
100
100
100
400
Operating margin %
357.8
-725.51
372.23
337.41
369.44
353.57
EBITDA margin %
—
—
—
—
—
—
Net margin %
-713.72
352.16
370.49
333.13
362.73
1 418.51
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.74
6.88
5.71
4.4
3.28
20.28
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
0.03
0.03
0.04
0.06
0.16
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
—
Per share metrics
Operating cash flow per share
-0.14
-0.13
0.18
0.21
0.16
0.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.44
1.3
2.15
1.76
1.54
6.75
Net current asset value per share
1.52
1.37
1.21
1.04
0.89
4.52
Tangible book value per share
0.24
0.13
0.03
0.2
0.36
0.72
Working capital per share
1.3
1.17
1
0.8
0.62
3.6
Book value per share
0.24
0.13
0.03
0.2
0.36
0.72
Noticias
Alibaba Earnings, Jobs Data
Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates
Wedbush rebaja Gossamer Bio tras resultados de ensayo
Wedbush rebaja Gossamer Bio tras resultados de ensayo clínico
Gossamer Bio stock downgraded by Wedbush on trial results
Barclays rebaja la calificación de Gossamer Bio tras resultados del ensayo
Barclays rebaja calificación de Gossamer Bio tras resultados de ensayo
Barclays cuts Gossamer Bio stock rating on trial results
Leerink rebaja la calificación de Gossamer Bio tras fracaso en ensayo
Leerink rebaja calificación de Gossamer Bio tras fallo en ensayo